BNIP3 as an atypical representative of the Bcl-2 protein family. Part 1: BNIP3, a regulator of non-apoptotic programmed cell death
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2009, Vol 63, Issue
Abstract
BNIP3 is classified as a member of the Bcl-2 protein family that regulates programmed cell death and of the BH3-only protein subfamily as it only contains one BH domain. However, the transmembrane domain of BNIP3 is involved in at least some of its pro-apoptotic functions. Although there are some similarities between BNIP3 and other BH3-only proteins, for example the ability to interact with anti-apoptotic Bcl-2 proteins and to induce cytochrome c release from mitochondria, BNIP3 is undoubtedly distinct in regard to its activity and regulatory mechanisms. Not only can BNIP3 activate apoptosis, but also, or perhaps first of all, it can activate necrosis-like cell death due to its direct interaction with the mitochondrial membrane. BNIP3 is also involved is autophagy, but its role in this process is not yet clearly understood. It is possible that the induction or stimulation of autophagy by this protein can simultaneously inhibit apoptosis, for example in cardiac myocytes. In some cells, BNIP3 is sequestered in the nucleus, where it also acts as an anti-apoptotic factor, namely as a repressor of AIF transcription. This activity may enable tumor cells to achieve resistance to chemotherapeutics. Understanding BNIP3 functions and regulatory mechanisms can point to new molecular targets in the treatment of cancer and ischemic heart or brain diseases.
Authors and Affiliations
Ewelina Swoboda, Leon Strządała
Effectiveness and safety of probiotic preparations in clinical treatment of inflammatory bowel disease
Inflammatory bowel disease (IBD) is characterized by an aggressive immune response to luminal antigens including those of commensal microbiota, which are essential for intestinal homeostasis and appear to play a role in...
The problems of urinary tract infections with Candida spp. aetiology in women
Urinary tract infections (UTIs) in women are a growing clinical concern. The most frequent risk factors of UTIs with fungal aetiology in women are: antibiotic therapy (especially broad-spectrum antibiotics), immunosuppre...
Wpływ czynników transkrypcyjnych na różnicowanie limfocytów T CD4[sup]+[/sup]
Wśród limfocytów T można wyodrębnić populacje komórek o wielorakich funkcjach i odmiennych szlakach różnicowania. Najbardziej zróżnicowaną grupę tworzą komórki mające na swojej powierzchni koreceptor CD4. Pod wpływem z...
Osmoregulacja – ważny parametr rozwoju bakterii
Warunki środowiskowe, takie jak temperatura, pH, promieniowanie czy ciśnienie osmotyczne stanowią ważne czynniki limitujące wzrost i rozmnażanie się bakterii. Prawidłowa struktura i metabolizm komórki bakteryjnej utrzymy...
Genetyczne i immunologiczne uwarunkowania odpowiedzi na dopęcherzową terapię BCG w raku urotelialnym pęcherza moczowego nienaciekającym błony mięśniowej
Rak pęcherza jest jednym z najczęściej występujących nowotworów złośliwych. W Polsce w 2010 r. zachorowało 6296, a zmarło 3110 osób. Immunoterapia BCG (Bacillus Calmette-Guérin) jest obecnie najskuteczniejszą terapią adi...